Alder BioPharmaceuticals
Why Robinhood?
You can watch ALDR and buy or sell other stocks, ETFs, and their options commission-free!About ALDR
Lundbeck Seattle BioPharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on transforming the migraine treatment paradigm through the discovery, development and commercialization of novel therapeutic antibodies. Its product includes Eptinezumab, is an investigational monoclonal antibody (mAb) that inhibits calcitonin gene-related peptide (CGRP) and is currently in late-stage clinical development for the prevention of migraine.
ALDR Key Statistics
Stock Snapshot
As of today, Alder BioPharmaceuticals(ALDR) shares are valued at $18.88. The company's market cap stands at 1.58B, with a P/E ratio of -4.24.
On 2026-10-09, Alder BioPharmaceuticals(ALDR) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for Alder BioPharmaceuticals(ALDR) stock has reached 0, versus its average volume of 5.3M.
The stock's 52-week range extends from a low of $8.39 to a high of $19.12.
The stock's 52-week range extends from a low of $8.39 to a high of $19.12.
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.